Multiparametric magnetic resonance imaging localizes established extracapsular extension of prostate cancer

• Published in: Urologic oncology Vol. 33; no. 3; pp. 109.e15 - 109.e22
• Main Authors: Feng, Tom S., M.D, Sharif-Afshar, Ali Reza, M.D, Smith, Steven C., M.D, Miller, Joseph, M.D, Nguyen, Christopher, Li, Quanlin, M.S, Luthringer, Daniel, M.D, Li, Debiao, Ph.D, Saouaf, Rola, M.D, Kim, Hyung L., M.D
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.03.2015
• Subjects: Aged; Cancer staging; Extracapsular extension; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Predictive Value of Tests; Prostate - pathology; Prostate cancer; Prostate-Specific Antigen - metabolism; Prostatectomy; Prostatic Neoplasms - diagnosis; Prostatic Neoplasms - pathology; Prostatic Neoplasms - surgery; Regression Analysis; Reproducibility of Results; ROC Curve; Seminal Vesicles - pathology; Urology; Magnetic resonance imaging; Extracapsular extension; Prostate cancer; Cancer staging
• DOI: 10.1016/j.urolonc.2014.11.007
• ISSN: 1078-1439

Abstract Objective To define the accuracy of multiparametric magnetic resonance imaging (MP-MRI) for identifying focal and established extracapsular extension (ECE) in various zones of the prostate. Methods Between 2010 and 2013, 342 patients underwent MP-MRI of the prostate (3 T, no endorectal coil with axial perfusion and diffusion images). The findings of the images were reported as negative, suspicious, or positive for ECE by a single expert radiologist. Radical prostatectomy specimens were reviewed to confirm the size and the location of ECE and further defined as focal or established ECE. Established ECE included extension that was multifocal or involving more than 5 glands. The accuracy of MRI in localizing focal and established ECE to each zone of the prostate was determined. Regression analyses were performed to identify predictors of ECE. Results We identified 112 patients who underwent prostate MP-MRI and radical prostatectomy. MRI findings considered suspicious or definite for ECE accurately predicted pathologic ECE ( P <0.001). MP-MRI identified established ECE but not focal ECE. Sensitivity, specificity, positive predictive value, and negative predictive value of MP-MRI for established ECE were 70.7%, 90.6%, 57.1%, and 95.1%, respectively. MRI identified ECE to the left vs. right side as well as each zone of the prostate; however, sensitivity was lowest at the apex. On multivariate analysis, MRI was a significant predictor of ECE that was independent of prostate-specific antigen level, Gleason score, and clinical stage. Conclusion MP-MRI is useful for identifying established but not focal ECE in all zones of the prostate. MRI was a significant independent predictor of established ECE and may be a useful adjunct in staging prostate cancer.